Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours Β· Estimated delivery Oct 9 - Oct 14
To move Epitalon from experimental to evidence-based, several developments are essential: Randomized, double-blind, placebo-controlled clinical trials, ideally targeting specific endpoints (sleep, immune aging, telomere attrition) Toxicology and long-term safety studies, including exploration of stereoisomer effects and off-target consequences Validated delivery systems (e.g., dendrimer-conjugates, transdermal patches) that make real-world use feasible Pharmacodynamic biomarkers, to identify responders and track efficacy objectively over time Epitalon is not snake oil, but its also not a magic bullet
Lynch has uncovered the biochemical reasons why some people tolerate glutathione beautifully while others dont
Possible irregularity from rapid weight loss
We accept credit & debit cards (including Apple Pay and Google Pay), SEPA / bank transfer, and cryptocurrency
Regulatory and safety status: Emideltide is not approved for use in humans and is currently pending FDA review
